BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29803205)

  • 1. Signs of impaired blood-brain barrier function and lower IgG synthesis within the central nervous system in patients with schizophrenia or related psychosis, compared to that in controls.
    Melkersson K; Bensing S
    Neuro Endocrinol Lett; 2018 Mar; 39(1):33-42. PubMed ID: 29803205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia.
    Kirch DG; Alexander RC; Suddath RL; Papadopoulos NM; Kaufmann CA; Daniel DG; Wyatt RJ
    J Neural Transm Gen Sect; 1992; 89(3):219-32. PubMed ID: 1389005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.
    Link H; Tibbling G
    Scand J Clin Lab Invest; 1977 Sep; 37(5):397-401. PubMed ID: 337461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humans.
    Wolkowitz OM; Papadopoulos NM; Costello R; Breier A; Doran AR; Pickar D; Rubinow D
    Psychoneuroendocrinology; 1990; 15(2):155-8. PubMed ID: 2359811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of CSF proteins as a measure of blood brain barrier function and synthesis of IgG within the CNS in 'normal' subjects from the age of 6 months to 30 years.
    Eeg-Olofsson O; Link H; Wigertz A
    Acta Paediatr Scand; 1981 Mar; 70(2):167-70. PubMed ID: 7234400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the minimal amount of IgG synthesized within the central nervous system in different neurological diseases.
    Kerényi L; Koltai M; Pálffy G
    Acta Med Acad Sci Hung; 1979; 36(4):367-73. PubMed ID: 122042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction.
    Winfield JB; Shaw M; Silverman LM; Eisenberg RA; Wilson HA; Koffler D
    Am J Med; 1983 May; 74(5):837-44. PubMed ID: 6837607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-cerebrospinal fluid barrier in schizophrenic patients.
    Bauer K; Kornhuber J
    Eur Arch Psychiatry Neurol Sci; 1987; 236(5):257-9. PubMed ID: 3653145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate.
    Tourtellotte WW; Potvin AR; Fleming JO; Murthy KN; Levy J; Syndulko K; Potvin JH
    Neurology; 1980 Mar; 30(3):240-4. PubMed ID: 7189023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the concentrations of cerebrospinal fluid immunoglobulin G and albumin in children.
    Hung KL; Chang MT; Tsai ML; Chen WC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(5):325-31. PubMed ID: 1296442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)].
    Cognazzo A; Gerbino Promis PC; Grasso E
    Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology.
    Müller N; Ackenheil M
    Schizophr Res; 1995 Feb; 14(3):223-8. PubMed ID: 7766533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination of elevated immunoglobulin concentrations in CSF due to inflammatory reaction of the central nervous system and blood-brain-barrier dysfunction.
    Eickhoff K; Heipertz R
    Acta Neurol Scand; 1977 Dec; 56(6):475-82. PubMed ID: 605772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG production within the central nervous system: a critical review of proposed formulae.
    Lefvert AK; Link H
    Ann Neurol; 1985 Jan; 17(1):13-20. PubMed ID: 3985580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier damage in children with central nervous system infections.
    Hung KL; Tsai ML; Chen WC
    J Formos Med Assoc; 1995 Aug; 94(8):458-62. PubMed ID: 7549573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid and Blood Biomarkers of Neuroinflammation and Blood-Brain Barrier in Psychotic Disorders and Individually Matched Healthy Controls.
    Jeppesen R; Orlovska-Waast S; Sørensen NV; Christensen RHB; Benros ME
    Schizophr Bull; 2022 Nov; 48(6):1206-1216. PubMed ID: 35939296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between agar gel electrophoresis and CSF serum quotients of IgG and albumin in neurological disease.
    Olsson JE; Pettersson B
    Acta Neurol Scand; 1976 Apr; 53(4):308-22. PubMed ID: 1266574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG.
    Frölich L; Kornhuber J; Ihl R; Fritze J; Maurer K; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(6):363-6. PubMed ID: 1831668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease.
    Singer EJ; Syndulko K; Fahy-Chandon B; Schmid P; Conrad A; Tourtellotte WW
    J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):265-71. PubMed ID: 7906304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia.
    Alafuzoff I; Adolfsson R; Bucht G; Winblad B
    J Neurol Sci; 1983; 60(3):465-72. PubMed ID: 6631444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.